Skip to content
Screener

CareDx CDNA Testing services revenue — Total Revenue

Other product segments

Patient and digital solutions revenue
$15.96M+33.5%

Similar metrics at other companies

Veracyte logo
VCYTTesting revenue — Total Revenue
$135.09M+25.9%
Veracyte logo
VCYTOther Testing Revenue — Total Revenue
$4.2M+950%
Soluna Holdings, Inc. logo
SLNHData hosting revenue — Total Revenue
$6.69M+178%
Globalstar logo
GSATTotal service revenue — Total Revenue
$60M-5.1%
HQY
HQYService revenue — Total Revenue
$122.93M+2.6%
Idexx Laboratories logo
IDXXService revenue — Total Revenue
$474.7M+11.6%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.32B+218%
Enterprise value$2.26B+228%
P/S5.6×+3.5×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue:
Testing services revenue$91,398$61,921
Product revenue10,34610,810
Patient and digital solutions revenue15,95611,954
Total revenue117,70084,685
Operating expenses:
Cost of testing services17,09715,113
Cost of product4,8345,586

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's testing services revenue — total revenue?
CareDx (CDNA) reported testing services revenue — total revenue of $91.4M in Q1 2026.
How has CareDx's testing services revenue — total revenue changed year-over-year?
CareDx's testing services revenue — total revenue increased by 47.6% year-over-year, from $61.92M to $91.4M.
What is the long-term trend for CareDx's testing services revenue — total revenue?
Over 4 years (2021 to 2025), CareDx's testing services revenue — total revenue has grown at a 1.4% compound annual growth rate (CAGR), from $259.29M to $274.5M.
What does testing services revenue — total revenue mean?
This metric represents the total gross revenue generated from the company's specialized testing services, products, and digital solutions provided to transplant patients and caregivers. It serves as a primary indicator of market adoption and commercial scale for the company's core genomics-based diagnostic offerings. Tracking this figure helps investors assess the growth trajectory and revenue-generating capacity of the firm's transplant-focused business segment.

Ask your AI about CareDx's testing services revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude